SLC16A1 and urinary bladder carcinoma: In light of these findings, our data strongly suggest that, via supporting the acquisition of a hybrid glycolysis/OXPHOS phenotype, E2F1-triggered activation of the SLC16A1/SLC16A1-AS1 gene pair promotes bladder cancer progression by mediating metabolic plasticity.